nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—mammary gland—lung cancer	0.078	0.241	CbGeAlD
Tyloxapol—LPL—respiratory system—lung cancer	0.052	0.16	CbGeAlD
Tyloxapol—LPL—bronchus—lung cancer	0.0428	0.132	CbGeAlD
Tyloxapol—LPL—trachea—lung cancer	0.0384	0.118	CbGeAlD
Tyloxapol—LPL—cardiac atrium—lung cancer	0.0361	0.111	CbGeAlD
Tyloxapol—LPL—bone marrow—lung cancer	0.0305	0.094	CbGeAlD
Tyloxapol—LPL—lung—lung cancer	0.0276	0.0851	CbGeAlD
Tyloxapol—LPL—lymph node—lung cancer	0.0189	0.0582	CbGeAlD
Tyloxapol—LPL—Diseases associated with visual transduction—APOA1—lung cancer	0.00442	0.00654	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—CASP8—lung cancer	0.00436	0.00645	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—VEGFA—lung cancer	0.00431	0.00638	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—NRAS—lung cancer	0.00426	0.0063	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—COL4A2—lung cancer	0.00418	0.00618	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—MTOR—lung cancer	0.00399	0.00591	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—MYC—lung cancer	0.00397	0.00587	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ROBO1—lung cancer	0.00388	0.00575	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—EGFR—lung cancer	0.00388	0.00574	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.00373	0.00552	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SLIT2—lung cancer	0.00372	0.00551	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—KRAS—lung cancer	0.00367	0.00543	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—HIF1A—lung cancer	0.00356	0.00528	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NODAL—lung cancer	0.00346	0.00512	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—CASP3—lung cancer	0.0033	0.00488	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—HRAS—lung cancer	0.00312	0.00461	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—EP300—lung cancer	0.00302	0.00446	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—RB1—lung cancer	0.0029	0.00429	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—COL4A3BP—lung cancer	0.00282	0.00417	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AZIN2—lung cancer	0.00282	0.00417	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—MAPK3—lung cancer	0.00265	0.00392	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.00263	0.00389	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SOX2—lung cancer	0.00262	0.00388	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.00255	0.00377	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NCOA3—lung cancer	0.00247	0.00365	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—PIK3CA—lung cancer	0.00244	0.0036	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NCAM1—lung cancer	0.0024	0.00355	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ATP5H—lung cancer	0.0024	0.00355	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.0022	0.00326	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PLBD1—lung cancer	0.00214	0.00316	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TP53—lung cancer	0.00211	0.00313	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.0021	0.00311	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—CDKN1A—lung cancer	0.00208	0.00308	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—AKT1—lung cancer	0.00199	0.00294	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HSD17B10—lung cancer	0.00195	0.00289	CbGpPWpGaD
Tyloxapol—LPL—Disease—PGAM1—lung cancer	0.00193	0.00286	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—STAT3—lung cancer	0.00186	0.00275	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CKB—lung cancer	0.00182	0.00269	CbGpPWpGaD
Tyloxapol—LPL—Disease—SDC4—lung cancer	0.00181	0.00267	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AXL—lung cancer	0.00179	0.00264	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CNDP2—lung cancer	0.00171	0.00253	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTM2—lung cancer	0.00171	0.00253	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTMR3—lung cancer	0.00166	0.00246	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—FOXO3—lung cancer	0.00165	0.00244	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PGAM1—lung cancer	0.00162	0.0024	CbGpPWpGaD
Tyloxapol—LPL—Disease—SKI—lung cancer	0.00159	0.00236	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ITGB1—lung cancer	0.00159	0.00235	CbGpPWpGaD
Tyloxapol—LPL—Disease—B4GALT5—lung cancer	0.00155	0.00229	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP2A7—lung cancer	0.00154	0.00229	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SDC4—lung cancer	0.00151	0.00224	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—HES1—lung cancer	0.00146	0.00216	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—COL4A2—lung cancer	0.00139	0.00206	CbGpPWpGaD
Tyloxapol—LPL—Disease—PXN—lung cancer	0.00138	0.00205	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—RRM1—lung cancer	0.00138	0.00204	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTA3—lung cancer	0.00138	0.00204	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GIPR—lung cancer	0.00135	0.002	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKR1C1—lung cancer	0.00135	0.002	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IL6—lung cancer	0.0013	0.00192	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—B4GALT5—lung cancer	0.00129	0.00192	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SDC4—lung cancer	0.00126	0.00187	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTA4—lung cancer	0.00126	0.00186	CbGpPWpGaD
Tyloxapol—LPL—Disease—NPPA—lung cancer	0.00125	0.00184	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—FGFR1—lung cancer	0.00124	0.00184	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DUSP3—lung cancer	0.00124	0.00183	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.00123	0.00182	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTA2—lung cancer	0.00123	0.00182	CbGpPWpGaD
Tyloxapol—LPL—Disease—PPIA—lung cancer	0.00122	0.0018	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RHEB—lung cancer	0.00121	0.0018	CbGpPWpGaD
Tyloxapol—LPL—Disease—ALDOA—lung cancer	0.00121	0.00179	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTA1—lung cancer	0.00118	0.00175	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KDR—lung cancer	0.00117	0.00173	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCC3—lung cancer	0.00117	0.00173	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GRM8—lung cancer	0.00115	0.0017	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MET—lung cancer	0.00115	0.0017	CbGpPWpGaD
Tyloxapol—LPL—Disease—ADCY1—lung cancer	0.00114	0.00169	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKR1C1—lung cancer	0.00113	0.00168	CbGpPWpGaD
Tyloxapol—LPL—Disease—ENO2—lung cancer	0.00112	0.00165	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SKI—lung cancer	0.00111	0.00165	CbGpPWpGaD
Tyloxapol—LPL—Disease—PPP2R1B—lung cancer	0.00111	0.00164	CbGpPWpGaD
Tyloxapol—LPL—Disease—SMARCA4—lung cancer	0.00111	0.00164	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—UGT1A1—lung cancer	0.0011	0.00163	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GNG11—lung cancer	0.00106	0.00157	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOA1—lung cancer	0.00106	0.00156	CbGpPWpGaD
Tyloxapol—LPL—Disease—ENO1—lung cancer	0.00102	0.0015	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALDOA—lung cancer	0.00101	0.0015	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—IL6R—lung cancer	0.001	0.00148	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CREBBP—lung cancer	0.001	0.00148	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NCOA3—lung cancer	0.000981	0.00145	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PXN—lung cancer	0.000968	0.00143	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	0.000964	0.00143	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP2—lung cancer	0.000956	0.00142	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MAP2K1—lung cancer	0.000955	0.00141	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCG2—lung cancer	0.000954	0.00141	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ADCY1—lung cancer	0.000954	0.00141	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GRP—lung cancer	0.000948	0.0014	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKR1C1—lung cancer	0.000948	0.0014	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—OXTR—lung cancer	0.000948	0.0014	CbGpPWpGaD
Tyloxapol—LPL—Disease—APP—lung cancer	0.000944	0.0014	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGF9—lung cancer	0.000936	0.00139	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HPGDS—lung cancer	0.000936	0.00139	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ENO2—lung cancer	0.000936	0.00139	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPP2R1B—lung cancer	0.00093	0.00138	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—POMC—lung cancer	0.000918	0.00136	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTT1—lung cancer	0.000908	0.00134	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GCLC—lung cancer	0.000897	0.00133	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP2A6—lung cancer	0.000897	0.00133	CbGpPWpGaD
Tyloxapol—LPL—Disease—JUNB—lung cancer	0.000894	0.00132	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	0.000894	0.00132	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GNG11—lung cancer	0.000887	0.00131	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ENO1—lung cancer	0.000851	0.00126	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	0.000847	0.00125	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RAF1—lung cancer	0.000847	0.00125	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFC—lung cancer	0.000845	0.00125	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ERBB2—lung cancer	0.000838	0.00124	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ALB—lung cancer	0.000837	0.00124	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADCY1—lung cancer	0.000798	0.00118	CbGpPWpGaD
Tyloxapol—LPL—Disease—FOXO3—lung cancer	0.000784	0.00116	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PPP2R1B—lung cancer	0.000778	0.00115	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SMARCA4—lung cancer	0.000778	0.00115	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP2E1—lung cancer	0.000763	0.00113	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NQO1—lung cancer	0.000754	0.00112	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HSPB1—lung cancer	0.00075	0.00111	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTHLH—lung cancer	0.000742	0.0011	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	0.000739	0.00109	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	0.000732	0.00108	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP9—lung cancer	0.000719	0.00106	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ANXA1—lung cancer	0.000697	0.00103	CbGpPWpGaD
Tyloxapol—LPL—Disease—HES1—lung cancer	0.000694	0.00103	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EP300—lung cancer	0.000682	0.00101	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—STK11—lung cancer	0.00068	0.00101	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FLT1—lung cancer	0.000676	0.001	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SRC—lung cancer	0.000663	0.000981	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APP—lung cancer	0.000661	0.000979	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH3—lung cancer	0.000661	0.000979	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGF9—lung cancer	0.000656	0.000971	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERCC2—lung cancer	0.000649	0.000961	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—VEGFA—lung cancer	0.000646	0.000955	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—STAT3—lung cancer	0.000639	0.000946	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTEN—lung cancer	0.000638	0.000945	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NRAS—lung cancer	0.000638	0.000944	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERBB3—lung cancer	0.000635	0.00094	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTP1—lung cancer	0.000629	0.000931	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JUNB—lung cancer	0.000626	0.000927	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CAT—lung cancer	0.000612	0.000906	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MAPK3—lung cancer	0.000611	0.000904	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—EP300—lung cancer	0.000609	0.000901	CbGpPWpGaD
Tyloxapol—LPL—Disease—TERT—lung cancer	0.000608	0.0009	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCB1—lung cancer	0.000596	0.000881	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGFR1—lung cancer	0.000591	0.000874	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TYMS—lung cancer	0.000585	0.000866	CbGpPWpGaD
Tyloxapol—LPL—Disease—HIF1A—lung cancer	0.000582	0.000861	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EGFR—lung cancer	0.000581	0.00086	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTM1—lung cancer	0.000578	0.000856	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STK11—lung cancer	0.000569	0.000841	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOA1—lung cancer	0.000562	0.000831	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KRAS—lung cancer	0.000549	0.000812	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FOXO3—lung cancer	0.000549	0.000812	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP1A1—lung cancer	0.000548	0.000811	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ERCC2—lung cancer	0.000544	0.000805	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AVP—lung cancer	0.000514	0.000761	CbGpPWpGaD
Tyloxapol—LPL—Disease—KIT—lung cancer	0.000513	0.000759	CbGpPWpGaD
Tyloxapol—LPL—Disease—APC—lung cancer	0.000513	0.000759	CbGpPWpGaD
Tyloxapol—LPL—Disease—EGF—lung cancer	0.000507	0.00075	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF1R—lung cancer	0.000495	0.000733	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HES1—lung cancer	0.000486	0.00072	CbGpPWpGaD
Tyloxapol—LPL—Disease—BRAF—lung cancer	0.000482	0.000713	CbGpPWpGaD
Tyloxapol—LPL—Disease—IL6R—lung cancer	0.000476	0.000704	CbGpPWpGaD
Tyloxapol—LPL—Disease—CREBBP—lung cancer	0.000475	0.000703	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOA1—lung cancer	0.00047	0.000696	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—HRAS—lung cancer	0.000466	0.00069	CbGpPWpGaD
Tyloxapol—LPL—Disease—MAP2K1—lung cancer	0.000454	0.000671	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CD—lung cancer	0.000451	0.000667	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	0.00045	0.000666	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—IL6—lung cancer	0.000446	0.000661	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ERBB3—lung cancer	0.000445	0.000658	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CG—lung cancer	0.000429	0.000635	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TERT—lung cancer	0.000426	0.000631	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGFR1—lung cancer	0.000414	0.000612	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT1—lung cancer	0.000412	0.00061	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—POMC—lung cancer	0.000409	0.000605	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HIF1A—lung cancer	0.000407	0.000603	CbGpPWpGaD
Tyloxapol—LPL—Disease—MDM2—lung cancer	0.000404	0.000598	CbGpPWpGaD
Tyloxapol—LPL—Disease—RAF1—lung cancer	0.000402	0.000595	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CREBBP—lung cancer	0.000398	0.000589	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERBB2—lung cancer	0.000398	0.000589	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOA1—lung cancer	0.000393	0.000582	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTOR—lung cancer	0.000393	0.000581	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CB—lung cancer	0.000393	0.000581	CbGpPWpGaD
Tyloxapol—LPL—Disease—CD4—lung cancer	0.000392	0.00058	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KDR—lung cancer	0.00039	0.000577	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTGS2—lung cancer	0.000389	0.000576	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CD—lung cancer	0.000377	0.000559	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALB—lung cancer	0.000373	0.000551	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APC—lung cancer	0.000359	0.000531	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CG—lung cancer	0.000359	0.000531	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KIT—lung cancer	0.000359	0.000531	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EGF—lung cancer	0.000355	0.000525	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—POMC—lung cancer	0.000342	0.000506	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN1A—lung cancer	0.00034	0.000503	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTEN—lung cancer	0.000339	0.000502	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—BRAF—lung cancer	0.000337	0.000499	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL6R—lung cancer	0.000333	0.000493	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CREBBP—lung cancer	0.000333	0.000493	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CB—lung cancer	0.000329	0.000487	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS2—lung cancer	0.000326	0.000482	CbGpPWpGaD
Tyloxapol—LPL—Disease—EP300—lung cancer	0.000324	0.000479	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAP2K1—lung cancer	0.000318	0.00047	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CD—lung cancer	0.000316	0.000467	CbGpPWpGaD
Tyloxapol—LPL—Disease—SRC—lung cancer	0.000315	0.000466	CbGpPWpGaD
Tyloxapol—LPL—Disease—STAT3—lung cancer	0.000304	0.000449	CbGpPWpGaD
Tyloxapol—LPL—Disease—NRAS—lung cancer	0.000303	0.000448	CbGpPWpGaD
Tyloxapol—LPL—Disease—MAPK3—lung cancer	0.00029	0.000429	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTEN—lung cancer	0.000284	0.000421	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MDM2—lung cancer	0.000283	0.000418	CbGpPWpGaD
Tyloxapol—LPL—Disease—MYC—lung cancer	0.000282	0.000417	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RAF1—lung cancer	0.000282	0.000417	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ERBB2—lung cancer	0.000279	0.000413	CbGpPWpGaD
Tyloxapol—LPL—Disease—EGFR—lung cancer	0.000276	0.000408	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MTOR—lung cancer	0.000275	0.000407	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CB—lung cancer	0.000275	0.000407	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—EP300—lung cancer	0.000271	0.000401	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCL8—lung cancer	0.000264	0.000391	CbGpPWpGaD
Tyloxapol—LPL—Disease—KRAS—lung cancer	0.000261	0.000386	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CASP3—lung cancer	0.000253	0.000374	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL2—lung cancer	0.000253	0.000374	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCND1—lung cancer	0.000246	0.000364	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JUN—lung cancer	0.000246	0.000364	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CA—lung cancer	0.000239	0.000354	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MMP9—lung cancer	0.000239	0.000354	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN1A—lung cancer	0.000238	0.000353	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTEN—lung cancer	0.000238	0.000352	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EP300—lung cancer	0.000227	0.000335	CbGpPWpGaD
Tyloxapol—LPL—Disease—HRAS—lung cancer	0.000222	0.000328	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SRC—lung cancer	0.00022	0.000326	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFA—lung cancer	0.000215	0.000318	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STAT3—lung cancer	0.000213	0.000315	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NRAS—lung cancer	0.000212	0.000314	CbGpPWpGaD
Tyloxapol—LPL—Disease—IL6—lung cancer	0.000212	0.000314	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK3—lung cancer	0.000203	0.000301	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CA—lung cancer	0.000201	0.000297	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MYC—lung cancer	0.000198	0.000292	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT1—lung cancer	0.000196	0.00029	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EGFR—lung cancer	0.000193	0.000286	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KRAS—lung cancer	0.000183	0.00027	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CA—lung cancer	0.000168	0.000248	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKT1—lung cancer	0.000164	0.000242	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TP53—lung cancer	0.000162	0.00024	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HRAS—lung cancer	0.000155	0.00023	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL6—lung cancer	0.000148	0.00022	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT1—lung cancer	0.000137	0.000203	CbGpPWpGaD
